<?xml version="1.0" encoding="UTF-8"?>
			<!DOCTYPE ijpp.edwiserinternational.com [
<!ELEMENT channel (title,link,description,language,managingEditor,webMaster,copyright,image,item,item,item,item,item)>
<!ELEMENT title (#PCDATA)>
<!ELEMENT link (#PCDATA)>
<!ELEMENT language (#PCDATA)>
<!ELEMENT managingEditor (#PCDATA)>
<!ELEMENT webMaster (#PCDATA)>
<!ELEMENT copyright (#PCDATA)>

<!ELEMENT image (title,link,url,width,height)>
<!ELEMENT url (#PCDATA)>
<!ELEMENT width (#PCDATA)>
<!ELEMENT height (#PCDATA)>

<!ELEMENT item (title,pubDate,link,author,comments,category,description)>
<!ELEMENT pubDate (#PCDATA)>
<!ELEMENT author (#PCDATA)>
<!ELEMENT comments (#PCDATA)>
<!ELEMENT category (#PCDATA)>
<!ELEMENT description (#PCDATA)>

]>
		<channel>
<title>Journal-of-Pharmaceutical-Research-Science-Technology-ISSUE VOLUME Volume 6 ISSUE Issue 2</title>
<link>http://ijpp.edwiserinternational.com/rss-feed.php</link>
<description>
Journal-of-Pharmaceutical-Research-Science-Technology: VOLUME Volume 6 ISSUE Issue 2, Jul-Dec 2022
</description>
<language>en-us</language>
<managingEditor>editor@edwiserinternational.com</managingEditor>
<webMaster>editor@edwiserinternational.com</webMaster>
<copyright>editor@edwiserinternational.com</copyright>
<image>
<title>Journal-of-Pharmaceutical-Research-Science-Technology-ISSUE VOLUME Volume 6 ISSUE Issue 2</title>
<link>http://ijpp.edwiserinternational.com/rss-feed.php</link>
<url>http://ijpp.edwiserinternational.com/img/logo1.png</url>
<width>360</width>
<height>109</height>
</image><item>
		<title>Evaluating-the-Prebiotic-Potential-of-Lepidium-Sativum-Seed-Mucilage-as-a-Nutraceutical-Ingredient</title>
		<pubDate>14-Jan-2023</pubDate>
<link>http://ijpp.edwiserinternational.com/admin/uploads/OqXdUJ.pdf</link>
		<author>Archana-Choudhary-S-Kalra-N</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[The current study investigates the prebiotic potential of Lepidium sativum L. seeds mucilage on different lactobacilli strains. The quantification of the total reducing sugar in the mucilage was attained by Ultraviolet-Visible Spectrophotometric method. The mucilage exhibited efcient resistance against -amylase and articial gastric juice hydrolysis compared to standard prebiotic inulin. The mucilage also exhibited efficient activity necessary for the augmentation of almost all strains of lactobacilli. In vitro studies also exhibited that lactobacilli amount was at par to standard prebiotics (p]]>}</description>
		</item><item>
		<title>Design-Formulation-and-Optimization-of-Peel-Off-Face-Mask-Gel-for-the-Symptomatic-Treatment-of-Rosacea</title>
		<pubDate>14-Jan-2023</pubDate>
<link>http://ijpp.edwiserinternational.com/admin/uploads/78gcAp.pdf</link>
		<author>Raju-T-Shamly-RAC-Nasrin-H-et-al-</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[The aim of this research work was to design formulate and optimization peel off face mask for the treatment of Rosacea. Among the 4 different types of rosacea, this research work aims to develop a user-friendly symptomatic treatment for the types which affect the facial skin. The peel off mask was formulated using 4%, 6%, 8%, 10% and 12% polyvinyl alcohol (PVA) as a gelling agent and the main ingredient was chamomile oil. Evaluation of peel off mask included physical characteristics (organoleptic properties, homogeneity, viscosity, spreadability, film drying time), chemical characteristics (pH value), stability and antimicrobial activity. The variation in PVA affects the pH value, viscosity and film drying time significantly. Stability test showed that all peel off mask show no significant changes at room temperature with and without exposure to sunlight and at low temperature. The peel off mask containing chamomile oil using 10% PVA has the inhibitory effect against bacteria (S. aureus, E. coli) and fungi (C. albicans) as compared with the positive controls (clindamycin gel, gentamycin and clotrimazole gel). Variation in the concentration of PVA in the formula affected the physical, chemical characteristic and antimicrobial activity of the chamomile oil peel off gel face mask significantly. The preparation using 10% PVA was found to be the best formula with optimal results and better antimicrobial action.]]>}</description>
		</item><item>
		<title>Evaluation-of-the-Efficacy-of-Pippalyadi-Basti-and-Lekhan-Basti-in-the-Management-of-Medoroga-with-Special-Reference-to-Obesity-A-Protocol</title>
		<pubDate>14-Jan-2023</pubDate>
<link>http://ijpp.edwiserinternational.com/admin/uploads/D5jBJF.pdf</link>
		<author>Wadhwa-R-Wairagade-S-Padavi-D-et-al-</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[Background: The conventional concept of etiopathogenesis, prognosis, and management of obesity is very similar and equally advanced to the Medoroga/Sthaulyaroga of Ayurveda, which was conceived in 1500 BC by Acharya Charaka. Overweight or obesity is mostly found in people with predominantly Kapha-type constitutions. According to Acharya Charak, apart from the genetic factors, diet (like shleshmakar, abhishayandi) & lifestyle (like avyayam, divaswapna) are the main contributing factors in the aetiopathogenesis of Medoroga. As per previous study Lekhana Basti was found to have moderate results in obesity. Pippalyadi has Chitraka and Pippali in addition to the other components of Lekahan basti so could have better results in correcting the vitiated Agni. Therefore, Pippalyadi basti is chosen for the current study.Objectives:To evaluate efficacy of Pippalyadi Basti in the management of Medoroga.To compare the efficacy with Lekhana BastiConceptual study of Medoroga in Ayurvedic texts and Obesity in modern medicine.Effect of Pippalyadi Basti & Lekhan Basti on B.M.I.Methodology: D.Y. Patil Ayurved Hospital, Samhitas & modern books of medicine, Pharmacy attached to college for the preparations of the drugs, international & national medical journals and magazines, OPD, IPD , Labs , other provisions of the hospitals will be availed to do this intended work.Expected Results: Changes will be observed in objective outcomes. Conclusion: Conclusion will be drawn by suitably analyzing data.]]>}</description>
		</item><item>
		<title>Application-of-Pharmaceutical-Coating-to-Avoid-SARS-COVID-2</title>
		<pubDate>14-Jan-2023</pubDate>
<link>http://ijpp.edwiserinternational.com/admin/uploads/FtTkrB.pdf</link>
		<author>Vikrant-Verma</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[To prevent the spread of COVID-19 infection, there is an urgent global demand for the protection of daily handling surfaces from viral contamination. To combat the present pandemic, nanotechnologists and material scientists offer sustainable options for developing antiviral surface coatings for various substrates such as fabrics, plastics, metal, wood, and food. They develop or propose antiviral surfaces by coating them with nanomaterials that interact with the SARS-CoV-2 spike protein to prevent the virus from infecting the host cell. It was discovered that polymer nanocomposites made from nanoparticles can be used to create useful coating materials. The numerous elements of antiviral nanocoatings are discussed in this article, including the method of interaction with the Corona Virus, the various types of nanocoatings developed for diverse substrates.]]>}</description>
		</item><item>
		<title>A-Concise-Review-on-Current-Omicron-Variants-and-Subvariants-SARS-Cov-2-and-Effective-Vaccines-against-them</title>
		<pubDate>16-Jan-2023</pubDate>
<link>http://ijpp.edwiserinternational.com/admin/uploads/mLhy2A.pdf</link>
		<author>Shahab-MS-Jahangir-MA</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[In late 2002 and early 2003, the SARS coronavirus and a new variant of the virus emerged in China and quickly spread around the globe. These viruses were easy to cultivate in tissue culture, which made it possible to study their genomic structure which were significantly different from human and animal coronavirus. The Covid-19 outbreak is a Group 2B Coronavirus. The genomic sequence of SARS-CoV-2 isolated from humans showed a similarity to SARS of 79.5%. The D614G mutation in the SARS-CoV-2 spikes was discovered at the beginning of March 2020. In the second wave of the SARS-COVID-2 epidemic in 2021, a number of novel COVID variants have been reported since the 2020 COVID outbreaks. The Omicron Variants, which were reported after the second wave in late 2021, is one of them. This concise review reports about Classification of new COVID-19 variants, Omicron variants and subvariants and their differences, and current vaccines in use against the newly mutated variants.]]>}</description>
		</item></channel>